# US 2004/0083505 A1 · Gene expression from the internal ribosome entry site (ires) of rhopalosiphum padi virus (rhpv)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0083505 A1
- Document ID: US20040083505A1
- Status: Published application
- Kind: A1
- Application number: 10/344,501
- Filed: 2003-07-28
- Published: 2004-04-29
- Earliest claimed: 2000-08-10
- Inventors: Lisa Oriel Roberts; Graham John Belsham
- Web page: https://patentgrep.com/patent/US20040083505A1

## CPC

- C07K 14/005: from viruses
- C12N 15/8216: {Methods for controlling, regulating or enhancing expression of transgenes in plant cells}
- C12N 15/8283: {for virus resistance}
- C12N 2770/22022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Polynucleotide sequence capable of directing translation initiation in a plant expression system in a cap-independent manner, wherein the polynucleotide sequence directs translation initiation from an AUG codon. In particular, the invention relates to a polynucleotide sequence which comprises the 5′ UTR of Rhopalosiphum padi virus (RhPV) which comprises an internal ribosome enty site (IRES).

## Claims

### Claim 1

A polynucleotide sequence capable of directing translation initiation in in vitro plant expression systems in a cap-independent manner and which directs translation initiation from an AUG or ATG codon, characterised in that the polynucleotide sequence comprises the 5′ UTR of RhPV, which has the sequence of SEQ ID NO. 1, or a variant thereof, the variant being capable of hybridising, when there is about 80% identity or more, with the antisense polynucleotide of SEQ ID NO. 1, under stringent conditions comprising 750 mM NaCl and 75 mM trisodium citrate, or less.

### Claim 2 (depends on 1)

A sequence according to claim 1, which is ss or ds DNA.

### Claim 3 (depends on 1, 2)

A sequence according to claim 1 or 2, which comprises an IRES element.

### Claim 4

A vector comprising at least one sequence according to any preceding claim.

### Claim 5 (depends on 4)

A vector according to claim 4, wherein the sequence is operably linked to one or more genes or open reading frames.

### Claim 6 (depends on 5)

A vector according to claim 5, wherein the first or only gene or open reading frame encodes a naturally occurring polypeptide having a 5′ methionine.

### Claim 7 (depends on 4, 5, 6)

A vector according to any of claims 4 to 6, wherein the expression of a selectable marker is operably linked with the sequence.

### Claim 8 (depends on 7)

A vector according to claim 7, wherein at least a second gene or open reading frame is operably linked with the sequence.

### Claim 9 (depends on 4, 5, 6, 7, 8)

An expression system containing a vector according to any of claims 4 to 8.

### Claim 10 (depends on 1)

A system according to claim 1, which is a plant cell or plant tissue.

### Claim 11 (depends on 4, 5, 6, 7, 8)

A plant containing a vector according to any of claims 4 to 8.

### Claim 12 (depends on 1, 2, 3)

A method for expressing a protein in a plant or plant expression system, comprising the steps of
1) linking a polynucleotide sequence according to any of claims 1 to 3 operably to a gene, open reading frame or polynucleotide sequence of interest;
2) expressing said gene, open reading frame or polynucleotide sequence in vivo or in vitro, such that the protein is produced; and
3) optionally purifying said protein.

### Claim 13 (depends on 1, 2, 3)

A method for the production of a transgenic plant, comprising the steps of:
1) operably linking a polynucleotide sequence according to any of claims 1 to 3 to a gene, open reading frame or polynucleotide sequence of interest;
2) recombining the linkage of step (1) into the genome of a suitable plant cell; and
3) culturing said plant cell to produce said transgenic plant.

### Claim 14 (depends on 1, 2, 3)

A method for treatment of viral infection in plants, comprising insertion into a plant cell of a gene or genes under translation control of a polynucleotide sequence according to any one of claims 1 to 3, wherein the protein expressed by the gene or genes assists in combating viral infection.

### Claim 15 (depends on 1, 2, 3)

A vector comprising a polynucleotide sequence according to any of claims 1 to 3 operably linked to a gene, open reading frame or polynucleotide sequence of interest, for use in the treatment of a viral infection in plants.
